Novartis AG is 41.7x more valuable than Grifols SA by market capitalization ($282.64 B vs $6.77 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GRFS | NVS |
|---|---|---|
| Market cap | $6.77 B | $282.64 B |
| US-listed rank | #1175 | #47 |
| SEC filings | 457 | 947 |
Novartis AG is 41.7x more valuable than Grifols SA by market capitalization ($282.64 B vs $6.77 B).
Full pages: Grifols SA and Novartis AG, or browse the full rankings.